Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:


Guest: Welcome to ChinaBio
® Today!

As a guest to ChinaBio® Today, you have access to summaries of over 3000 articles including our archives.  You can use the Search feature on the left menu bar to find what you're looking for, or you can browse summaries of our articles by the categories listed under Subscriber Articles. You can access any article that is marked as FREE. Or you can subscribe and have access to our entire content.   

Top Stories

>> See all top stories...

Recent Articles

Recent Articles

  Week in Review: WuXi AppTec Acquires HD Biosciences in China CRO Tieup (in: Week in Review)
  WuXi AppTec Acquires HD Biosciences, a Biologics CRO (in: Deals & Financings)
  RMX Acquires China Rights to Novel Antibiotic from LegoChem (in: Deals & Financings)
  Tencent Leads $55 Million Investment in Indian Mobile Healthcare App (in: Deals & Financings)
  Renhe Partners with Applied Pharma to Market Migraine Drug in China (in: Deals & Financings)
  New Century Healthcare Raises $114 Million in Hong Kong IPO (in: Deals & Financings)
  WuXi-MedImmune RA Biologic Approved for China Trials (in: Trials & Approvals)
  Yiling Pharma Invests $20 Million in Israel's HealthWatch (in: Deals & Financings)
  CloudHealth Genomics Launches Liquid Biopsy for Very Early China Screening (in: News & Analysis)
  Week in Review: China's Sanpower Pays $820 for Provenge, a Prostate Immunotherapy (in: Week in Review)